The GSEA results showed that several pathways were activated in the DACH1 low expression group (Supplementary Material 4), such as transcriptional misregulation in cancer, ECM-receptor interaction, and the NF-kappa B signaling pathway (Figure 10). This evidence concerns the gene DACH1 and cancer.